Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome
Open Access
- 1 August 2009
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 161 (2) , 251-257
Abstract
Context: Reduced bone mineral density (BMD) and increased risk of fractures are present in many women with Turner syndrome (TS).Objective: Examine longitudinal changes in BMD in TS and relate changes to biochemical parameters.Design: Prospective, pragmatic, and observational study. Examinations at baseline and follow-up (5.9±0.7 years).Setting: Tertiary hospital.Participants: Fifty-four women with TS (43.0±9.95 years).Interventions: Hormone replacement therapy (HRT) and calcium and vitamin D supplementation.Main outcome measures: BMD (g/cm2) measured at lumbar spine, hip, and the non-dominant forearm. Bone formation and resorption markers, sex hormones, IGF1, and maximal oxygen uptake.Results: At follow-up, forearm BMD, radius ultradistal BMD, and hip BMD remained unchanged, radius 1/3 BMD declined (0.601±0.059 vs 0.592±0.059, P=0.03), while spine BMD increased (0.972±0.139 vs 1.010±0.144, P<0.0005). Bone formation markers did not change over time in TS. Bone resorption markers decreased over time in TS. Testosterone, IGF1, and maximal oxygen uptake was significantly reduced in TS.Conclusion: Longitudinal changes in BMD in TS were slight. BMD can be maintained at most sites in well-informed women with TS, being encouraged to maintain a healthy lifestyle, including HRT and intake of calcium and vitamin D.Keywords
This publication has 29 references indexed in Scilit:
- Declining Estrogen Use in Young Women With Turner SyndromeArchives of internal medicine (1960), 2006
- Bone mineral density and fractures in Turner syndromeThe American Journal of Medicine, 2003
- Increased fracture rates in Turner's syndrome: a nationwide questionnaire surveyClinical Endocrinology, 2003
- Morbidity in Turner SyndromeJournal of Clinical Epidemiology, 1998
- Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndromeNature Genetics, 1997
- Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradationClinical Chemistry, 1993
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992
- Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with turner's syndromeJournal of Bone and Mineral Research, 1989
- Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.Clinical Chemistry, 1988
- Daily physical activity, work capacity and glucose tolerance in lean and obese normoglycaemic middle-aged menDiabetologia, 1981